• LAST PRICE
    62.2600
  • TODAY'S CHANGE (%)
    Trending Up1.7500 (2.8921%)
  • Bid / Lots
    59.0000/ 2
  • Ask / Lots
    65.5200/ 1
  • Open / Previous Close
    60.5200 / 60.5100
  • Day Range
    Low 59.2000
    High 62.6900
  • 52 Week Range
    Low 18.2500
    High 77.6000
  • Volume
    263,991
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 60.51
TimeVolumeIRON
09:32 ET131360.6357
09:34 ET319460.055
09:36 ET10059.61
09:57 ET40059.61
09:59 ET36059.45
10:01 ET10059.445
10:10 ET50059.26
10:14 ET63559.46
10:15 ET40059.5
10:19 ET10059.64
10:26 ET20059.56
10:35 ET20059.74
10:44 ET10059.87
10:46 ET20059.965
10:51 ET50660.14
10:55 ET100560.275
10:57 ET50060.065
11:00 ET10060.19
11:02 ET10060.08
11:11 ET30060.16
11:13 ET180060.67
11:15 ET10060.67
11:18 ET40060.75
11:31 ET10061.48
11:42 ET99961.33
11:45 ET10061.19
11:56 ET10061.11
12:02 ET30060.875
12:05 ET60060.48
12:07 ET10060.455
12:09 ET20060.445
12:12 ET10060.45
12:21 ET1329560.725
12:25 ET251660.8
12:27 ET149960.755
12:32 ET212460.77
12:39 ET10060.69
12:41 ET10060.805
12:43 ET40060.52
12:45 ET10060.63
12:50 ET30060.63
12:52 ET33460.56
12:54 ET10060.41
12:57 ET40060.555
12:59 ET10060.43
01:01 ET120060.575
01:03 ET161360.92
01:06 ET40061.115
01:08 ET50061.2
01:10 ET40061.3
01:14 ET10061.22
01:15 ET10061.16
01:17 ET10061.13
01:24 ET97961.22
01:26 ET91361.125
01:28 ET109161.115
01:30 ET10061.125
01:32 ET108261.055
01:33 ET10060.95
01:37 ET10060.83
01:39 ET245961.44
01:42 ET10061.66
01:48 ET20061.485
01:50 ET229461.55
01:51 ET73961.54
01:53 ET20061.54
01:55 ET153461.76
01:57 ET30062
02:00 ET25561.905
02:02 ET40061.59
02:06 ET135061.24
02:09 ET20061.35
02:11 ET10061.36
02:13 ET94761.63
02:18 ET38361.64
02:22 ET26761.39
02:24 ET10061.345
02:26 ET10061.33
02:31 ET10061.43
02:33 ET74861.31
02:36 ET40061.31
02:40 ET10061.27
02:44 ET20061.39
02:45 ET110061.43
02:47 ET40061.5
02:49 ET30061.635
02:51 ET10061.68
02:56 ET10061.58
02:58 ET10061.52
03:00 ET20061.58
03:02 ET240061.985
03:03 ET20062.03
03:05 ET20061.945
03:07 ET10062
03:09 ET30062.16
03:12 ET50062.27
03:14 ET40062.255
03:16 ET70062.395
03:18 ET10062.51
03:20 ET30062.48
03:21 ET100062.35
03:23 ET70062.03
03:25 ET10062.135
03:27 ET20062.13
03:30 ET110062.29
03:32 ET70062.25
03:34 ET35662.25
03:36 ET210061.985
03:38 ET32061.975
03:39 ET51061.97
03:41 ET180062.125
03:43 ET10062.135
03:45 ET40062.165
03:48 ET40062.18
03:50 ET40062.19
03:52 ET34862.19
03:54 ET300062.555
03:56 ET810962.55
03:57 ET310062.475
03:59 ET7522662.26
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIRON
Disc Medicine Inc
1.5B
-8.4x
---
United StatesKURA
Kura Oncology Inc
1.6B
-10.2x
---
United StatesDAWN
Day One Biopharmaceuticals Inc
1.4B
-7.0x
---
United StatesINBX
Inhibrx Inc
1.7B
-7.0x
---
United StatesSLNO
Soleno Therapeutics Inc
1.4B
-14.4x
---
United StatesAKRO
Akero Therapeutics Inc
1.7B
-8.9x
---
As of 2024-03-29

Company Information

Disc Medicine, Inc. is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps) including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.

Contact Information

Headquarters
321 Arsenal Street, Suite 101WATERTOWN, MA, United States 02472
Phone
617-674-9274
Fax
302-655-5049

Executives

Executive Chairman of the Board
Donald Nicholson
President, Chief Executive Officer, Director
John Quisel
Chief Financial Officer, Treasurer
Jean Franchi
Chief Operating Officer
Jonathan Yu
General Counsel
Rahul Khara

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$0.00
Shares Outstanding
24.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.17
EPS
$-7.44
Book Value
$19.83
P/E Ratio
-8.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.